MKK3- and MKK6-Regulated Gene Expression Is Mediated by the p38 Mitogen-Activated Protein Kinase Signal Transduction Pathway
Open Access
- 1 March 1996
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 16 (3) , 1247-1255
- https://doi.org/10.1128/mcb.16.3.1247
Abstract
The p38 mitogen-activated protein (MAP) kinase signal transduction pathway is activated by proinflammatory cytokines and environmental stress. The detection of p38 MAP kinase in the nucleus of activated cells suggests that p38 MAP kinase can mediate signaling to the nucleus. To test this hypothesis, we constructed expression vectors for activated MKK3 and MKK6, two MAP kinase kinases that phosphorylate and activate p38 MAP kinase. Expression of activated MKK3 and MKK6 in cultured cells caused a selective increase in p38 MAP kinase activity. Cotransfection experiments demonstrated that p38 MAP kinase activation causes increased reporter gene expression mediated by the transcription factors ATF2 and Elk-1. These data demonstrate that the nucleus is one target of the p38 MAP kinase signal transduction pathway.Keywords
This publication has 70 references indexed in Scilit:
- MAPKs: new JNK expands the groupPublished by Elsevier ,2002
- Cdc42 and PAK-mediated Signaling Leads to Jun Kinase and p38 Mitogen-activated Protein Kinase ActivationJournal of Biological Chemistry, 1995
- Rho Family GTPases Regulate p38 Mitogen-activated Protein Kinase through the Downstream Mediator Pak1Journal of Biological Chemistry, 1995
- Transformation of Mammalian Cells by Constitutively Active MAP Kinase KinaseScience, 1994
- A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian CellsScience, 1994
- The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domainCell, 1993
- The mitogen-activated protein kinase activatorCurrent Opinion in Cell Biology, 1992
- ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGFCell, 1991
- Site-directed mutagenesis by overlap extension using the polymerase chain reactionGene, 1989
- GAL4-VP16 is an unusually potent transcriptional activatorNature, 1988